Human Regulatory T Cells with Alloantigen Specificity Are More Potent Inhibitors of Alloimmune Skin Graft Damage than Polyclonal Regulatory T Cells
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Human Regulatory T Cells with Alloantigen Specificity Are More Potent Inhibitors of Alloimmune Skin Graft Damage than Polyclonal Regulatory T Cells
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 3, Issue 83, Pages 83ra42-83ra42
Publisher
American Association for the Advancement of Science (AAAS)
Online
2011-05-19
DOI
10.1126/scitranslmed.3002076
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Location and Time-Dependent Control of Rejection by Regulatory T Cells Culminates in a Failure to Generate Memory T Cells
- (2014) M. Carvalho-Gaspar et al. JOURNAL OF IMMUNOLOGY
- Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal
- (2010) K. E. Lamb et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Adoptive regulatory T cell therapy: challenges in clinical transplantation
- (2010) Niloufar Safinia et al. Current Opinion in Organ Transplantation
- In vivo prevention of transplant arteriosclerosis by ex vivo–expanded human regulatory T cells
- (2010) Satish N Nadig et al. NATURE MEDICINE
- NOD-scid IL2rγnull Mouse Model of Human Skin Transplantation and Allograft Rejection
- (2010) Waldemar J. Racki et al. TRANSPLANTATION
- The Generation of Donor-Specific CD4+CD25++CD45RA+ Naive Regulatory T Cells in Operationally Tolerant Patients After Pediatric Living-Donor Liver Transplantation
- (2010) Hanaa Nafady-Hego et al. TRANSPLANTATION
- Ex Vivo–Expanded Human Regulatory T Cells Prevent the Rejection of Skin Allografts in a Humanized Mouse Model
- (2010) Fadi Issa et al. TRANSPLANTATION
- Functional characterization of alloreactive T cells identifies CD25 and CD71 as optimal targets for a clinically applicable allodepletion strategy
- (2009) S. Samarasinghe et al. BLOOD
- Ability of the polysaccharide chitosan to inhibit proliferation of CD4+ lymphocytes from mucosal inductive sites, in vitro and in vivo
- (2009) C. Porporatto et al. CELL PROLIFERATION
- First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells
- (2009) Piotr Trzonkowski et al. CLINICAL IMMUNOLOGY
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
- (2009) Makoto Miyara et al. IMMUNITY
- Direct Expansion of Human Allospecific FoxP3+CD4+ Regulatory T Cells with Allogeneic B Cells for Therapeutic Application
- (2009) L. C. Chen et al. JOURNAL OF IMMUNOLOGY
- CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis
- (2009) J. M. Fletcher et al. JOURNAL OF IMMUNOLOGY
- Expansion of Allospecific Regulatory T Cells After Anergized, Mismatched Bone Marrow Transplantation
- (2009) J. K. Davies et al. Science Translational Medicine
- Indefinite mouse heart allograft survival in recipient treated with CD4+CD25+ regulatory T cells with indirect allospecificity and short term immunosuppression
- (2009) Julia Yuen-Shan Tsang et al. TRANSPLANT IMMUNOLOGY
- Regulatory T cells as therapeutic cells
- (2008) Pervinder Sagoo et al. Current Opinion in Organ Transplantation
- Expansion of Human Regulatory T-Cells From Patients With Type 1 Diabetes
- (2008) A. L. Putnam et al. DIABETES
- Regulatory T cells after organ transplantation: Where does their action take place?
- (2008) I. Esmé Dijke et al. HUMAN IMMUNOLOGY
- Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice
- (2008) Julia Yuen-Shan Tsang et al. JOURNAL OF CLINICAL INVESTIGATION
- Ex Vivo Generation of Human Alloantigen-Specific Regulatory T Cells from CD4posCD25high T Cells for Immunotherapy
- (2008) Jorieke H. Peters et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search